Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Enzon PharmaceuticalsaTyr PharmaBiondVax PharmaceuticalsAcorda TherapeuticsBioCardia
SymbolOTCMKTS:ENZNNASDAQ:LIFENASDAQ:BVXVNASDAQ:ACORNASDAQ:BCDA
Price Information
Current Price$0.65$3.77$3.09$4.19$3.98
52 Week RangeN/ABuyN/AHoldBuy
MarketRank™
Overall Score0.61.50.51.41.5
Analysis Score0.03.50.03.03.3
Community Score2.82.32.52.22.5
Dividend Score0.00.00.00.00.0
Ownership Score0.00.80.00.00.8
Earnings & Valuation Score0.00.60.01.90.6
Analyst Ratings
Consensus RecommendationN/ABuyN/AHoldBuy
Consensus Price TargetN/A$15.67N/A$23.67$9.25
% Upside from Price TargetN/A315.56% upsideN/A464.84% upside132.41% upside
Trade Information
Market Cap$48.24 million$60.36 million$35.08 million$39.76 million$65.03 million
Beta0.772.172.410.751.98
Average Volume285,6241,406,545939,693920,286293,513
Sales & Book Value
Annual Revenue$210,000.00$420,000.00N/A$192.41 million$710,000.00
Price / Sales229.71143.72N/A0.2191.59
CashflowN/AN/AN/A$18.22 per shareN/A
Price / CashN/AN/AN/A0.23N/A
Book Value$0.14 per share$5.40 per share($2.88) per share$38.82 per share$0.35 per share
Price / Book4.640.70N/A0.1111.37
Profitability
Net Income$-980,000.00$-23,600,000.00$-31,600,000.00$-272,970,000.00$-14,710,000.00
EPSN/A($7.03)($3.60)($11.94)($2.61)
Trailing P/E Ratio0.00N/AN/A0.76N/A
Forward P/E RatioN/AN/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net Margins-1,711.94%-202.02%N/A29.71%-5,103.95%
Return on Equity (ROE)-20.29%-52.75%N/A-8.60%-496.87%
Return on Assets (ROA)-18.69%-38.40%-135.18%-3.51%-178.90%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity RatioN/AN/AN/A0.52%0.05%
Current Ratio8.91%4.76%6.48%1.09%1.99%
Quick Ratio8.91%4.76%6.48%0.88%1.99%
Ownership Information
Institutional Ownership PercentageN/A55.82%4.04%N/A9.01%
Insider Ownership Percentage0.03%9.44%6.03%6.80%40.90%
Miscellaneous
EmployeesN/A392516724
Shares Outstanding74.22 million16.01 million11.35 million9.49 million16.34 million
Next Earnings Date4/29/2021 (Estimated)5/11/2021 (Estimated)6/29/2021 (Estimated)5/4/2021 (Estimated)5/21/2021 (Estimated)
OptionableNot OptionableOptionableNot OptionableOptionableNot Optionable
SourceHeadline
BioCardia (NASDAQ:BCDA) Downgraded by Dawson JamesBioCardia (NASDAQ:BCDA) Downgraded by Dawson James
americanbankingnews.com - April 17 at 2:58 PM
BioCardia, Inc. (NASDAQ:BCDA) Sees Significant Increase in Short InterestBioCardia, Inc. (NASDAQ:BCDA) Sees Significant Increase in Short Interest
americanbankingnews.com - April 17 at 1:00 AM
Steerable Introducers Market Size by Recent Developments 2021 Business Trends Evaluation, Leading Players Updates – Merit Medical, Boston Scientific, Abbott, BioCardia, Integer - Los Hijos de la MalincheSteerable Introducers Market Size by Recent Developments 2021 Business Trends Evaluation, Leading Players Updates – Merit Medical, Boston Scientific, Abbott, BioCardia, Integer - Los Hijos de la Malinche
loshijosdelamalinche.com - April 15 at 8:42 AM
Should You Take Comfort From Insider Transactions At BioCardia, Inc. (NASDAQ:BCDA)? - NasdaqShould You Take Comfort From Insider Transactions At BioCardia, Inc. (NASDAQ:BCDA)? - Nasdaq
nasdaq.com - April 8 at 2:13 PM
SRNE Stock - SRNE Stock - BUZZ-US STOCKS ON THE MOVE-Infinity Pharmaceuticals, BioCardia, Caesars Entertainment, TransMedics Group | Fintech Zoom - Fintech ZoomSRNE Stock - SRNE Stock - BUZZ-US STOCKS ON THE MOVE-Infinity Pharmaceuticals, BioCardia, Caesars Entertainment, TransMedics Group | Fintech Zoom - Fintech Zoom
fintechzoom.com - April 3 at 9:47 PM
Sorrento Therapeutics, Inc. (SRNE) Stock Price, News - Fintech ZoomSorrento Therapeutics, Inc. (SRNE) Stock Price, News - Fintech Zoom
fintechzoom.com - April 3 at 9:47 PM
SRNE Stock - BUZZ-US STOCKS ON THE MOVE-Infinity Pharmaceuticals, BioCardia, Caesars Entertainment, TransMedics Group - Fintech ZoomSRNE Stock - BUZZ-US STOCKS ON THE MOVE-Infinity Pharmaceuticals, BioCardia, Caesars Entertainment, TransMedics Group - Fintech Zoom
fintechzoom.com - April 3 at 4:46 PM
Have Insiders Been Buying BioCardia, Inc. (NASDAQ:BCDA) Shares? - Yahoo FinanceHave Insiders Been Buying BioCardia, Inc. (NASDAQ:BCDA) Shares? - Yahoo Finance
finance.yahoo.com - April 1 at 10:13 AM
Have Insiders Been Buying BioCardia, Inc. (NASDAQ:BCDA) Shares?Have Insiders Been Buying BioCardia, Inc. (NASDAQ:BCDA) Shares?
finance.yahoo.com - April 1 at 7:19 AM
BioCardia Reports 2020 Financial Results and Recent Business Highlights - GlobeNewswireBioCardia Reports 2020 Financial Results and Recent Business Highlights - GlobeNewswire
globenewswire.com - April 1 at 5:13 AM
Tencent To Buy Back $1B In Stock; Shares Gain Pre-Market - NasdaqTencent To Buy Back $1B In Stock; Shares Gain Pre-Market - Nasdaq
nasdaq.com - March 31 at 8:39 AM
BioCardia (NASDAQ:BCDA) Posts  Earnings Results, Beats Expectations By $0.15 EPSBioCardia (NASDAQ:BCDA) Posts Earnings Results, Beats Expectations By $0.15 EPS
americanbankingnews.com - March 31 at 7:50 AM
4 Stocks Poised to Gain From Uptick in Campus Networking Spend - Nasdaq4 Stocks Poised to Gain From Uptick in Campus Networking Spend - Nasdaq
nasdaq.com - March 30 at 10:38 PM
Deutsche (DB) Might File Lawsuit Against Two Ex-Madoff Funds - NasdaqDeutsche (DB) Might File Lawsuit Against Two Ex-Madoff Funds - Nasdaq
nasdaq.com - March 30 at 12:50 PM
BlackBerry (BB) QNX Software Boosts Scanias Heavy Vehicles - NasdaqBlackBerry (BB) QNX Software Boosts Scania's Heavy Vehicles - Nasdaq
nasdaq.com - March 30 at 12:37 PM
Viasat (VSAT) Arm Sets Up Facility in UK to Boost Cybersecurity - NasdaqViasat (VSAT) Arm Sets Up Facility in UK to Boost Cybersecurity - Nasdaq
nasdaq.com - March 30 at 12:37 PM
Form 10-K BioCardia, Inc. For: Dec 31 - StreetInsider.comForm 10-K BioCardia, Inc. For: Dec 31 - StreetInsider.com
streetinsider.com - March 30 at 12:37 PM
BioCardia, Inc. (BCDA) Reports Q4 Loss, Misses Revenue Estimates - Yahoo FinanceBioCardia, Inc. (BCDA) Reports Q4 Loss, Misses Revenue Estimates - Yahoo Finance
finance.yahoo.com - March 30 at 12:37 PM
BioCardia Reports 2020 Financial Results and Recent Business Highlights - Yahoo FinanceBioCardia Reports 2020 Financial Results and Recent Business Highlights - Yahoo Finance
finance.yahoo.com - March 30 at 12:37 PM
BioCardia, Inc. (BCDA) Reports Q4 Loss, Misses Revenue EstimatesBioCardia, Inc. (BCDA) Reports Q4 Loss, Misses Revenue Estimates
finance.yahoo.com - March 30 at 12:36 PM
BioCardia Reports 2020 Financial Results and Recent Business HighlightsBioCardia Reports 2020 Financial Results and Recent Business Highlights
finance.yahoo.com - March 30 at 9:16 AM
BIOCARDIA, INC. : Entry into a Material Definitive Agreement, Financial Statements and Exhibits (form 8-K) - marketscreener.comBIOCARDIA, INC. : Entry into a Material Definitive Agreement, Financial Statements and Exhibits (form 8-K) - marketscreener.com
marketscreener.com - March 29 at 6:14 PM
-$0.31 EPS Expected for BioCardia, Inc. (NASDAQ:BCDA) This Quarter-$0.31 EPS Expected for BioCardia, Inc. (NASDAQ:BCDA) This Quarter
americanbankingnews.com - March 28 at 6:12 PM
BioCardia Is Super Cheap With Multiple Shots On Goal - Seeking AlphaBioCardia Is Super Cheap With Multiple Shots On Goal - Seeking Alpha
seekingalpha.com - March 25 at 2:07 PM
BioCardia - Consensus Indicates Potential 144.4% Upside - DirectorsTalk InterviewsBioCardia - Consensus Indicates Potential 144.4% Upside - DirectorsTalk Interviews
directorstalkinterviews.com - March 22 at 1:00 AM
DateCompanyBrokerageAction
3/30/2021aTyr PharmaOppenheimerBoost Price Target
3/22/2021aTyr PharmaRoth CapitalBoost Price Target
8/17/2020aTyr PharmaHC WainwrightUpgrade
8/30/2019aTyr PharmaCitigroupSet Price Target
3/26/2019aTyr PharmaWilliam BlairReiterated Rating
10/8/2018aTyr PharmaPiper Jaffray CompaniesLower Price Target
8/15/2018aTyr PharmaBMO Capital MarketsLower Price Target
1/13/2021Acorda TherapeuticsCowenBoost Price Target
8/11/2020Acorda TherapeuticsJefferies Financial GroupReiterated Rating
2/16/2020Acorda TherapeuticsJPMorgan Chase & Co.Reiterated Rating
8/2/2019Acorda TherapeuticsStifel NicolausLower Price Target
8/2/2019Acorda TherapeuticsWedbushLower Price Target
8/2/2019Acorda TherapeuticsCantor FitzgeraldLower Price Target
4/16/2021BioCardiaDawson JamesDowngrade
9/21/2020BioCardiaAlliance Global PartnersInitiated Coverage
8/14/2020BioCardiaMaxim GroupInitiated Coverage
11/26/2019BioCardiaBrookline Capital ManagementReiterated Rating
(Data available from 4/18/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.